{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:12:07Z","timestamp":1789647127128,"version":"4.0.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejps.2020.105596","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T01:17:18Z","timestamp":1602811038000},"page":"105596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Antibacterial activity of new substituted 4-N-alkylated-2-trifluoromethyl-quinoline analogues against sensitive and resistant Mycobacterium tuberculosis strains"],"prefix":"10.1016","volume":"157","author":[{"given":"Emerson Teixeira","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9896-6385","authenticated-orcid":false,"given":"Gabriel Fernandes","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriele da Silva","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina Silva","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vin\u00edcius Nora","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2020.105596_bib0001","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2174\/1568026619666190304124952","article-title":"Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains","volume":"19","author":"Ara\u00fajo","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.ejps.2020.105596_bib0002","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/1389557518666181018163448","article-title":"A Review on Quinoline Derived Scaffolds as Anti-HIV Agents","volume":"19","author":"Chokkar","year":"2019","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.ejps.2020.105596_bib0003","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ptr.2650080312","article-title":"Antiprotozoal Activity of Quinoline Alkaloids Isolated from Gal\u00ecpea longijlora, a Bolivian Plant Used as a Treatment for Cutaneous Leishmaniasis","volume":"8","author":"Fournet","year":"1994","journal-title":"Phytotherapy Res"},{"key":"10.1016\/j.ejps.2020.105596_bib0004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ejps.2020.105596_bib0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bmc.2011.11.006","article-title":"Mefloquine-oxazolidine derivatives, derived from mefloquine and arenecarbaldehydes: In vitro activity including against the multidrug-resistant tuberculosis strain T113","volume":"20","author":"Gon\u00e7alves","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ejps.2020.105596_bib0006","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/jac\/dkv054","article-title":"Bactericidal mode of action of Bedaquiline","volume":"70","author":"Hards","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejps.2020.105596_bib0007","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.biopha.2014.10.007","article-title":"Quinoline: A promising antitubercular target","volume":"68","author":"Keri","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ejps.2020.105596_bib0008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MCP.0000000000000570","article-title":"New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease","volume":"25","author":"Leea","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ejps.2020.105596_bib0009","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/jhet.3241","article-title":"Quinoline Derivatives with Potential Activity Against Multidrug-resistant Tuberculosis","volume":"55","author":"Liu","year":"2018","journal-title":"J Heterocyclic Chem"},{"key":"10.1016\/j.ejps.2020.105596_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ejps.2020.105596_bib0011","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.2174\/1385272821666170207103634","article-title":"Quinoline Alkaloids Against Neglected Tropical Diseases","volume":"21","author":"Musiol","year":"2017","journal-title":"Cur Org Chem"},{"key":"10.1016\/j.ejps.2020.105596_bib0012","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejmech.2018.11.026","article-title":"Green recipes to quinoline: A review","volume":"164","author":"Nainwal","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ejps.2020.105596_bib0013","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1007\/s11164-016-2794-2","article-title":"Synthesis and therapeutic potential of quinoline derivatives","volume":"43","author":"Narwal","year":"2017","journal-title":"Res Chem Intermed"},{"key":"10.1016\/j.ejps.2020.105596_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules21080986","article-title":"Recent Advances in Metal-Free Quinoline Synthesis","volume":"21","author":"Ramann","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2020.105596_bib0016","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/med.21466","article-title":"Lee K-H. Biologically active quinoline and quinazoline alkaloids part I","volume":"38","author":"Shang","year":"2018","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ejps.2020.105596_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12039-018-1466-8","article-title":"A review on transition-metal mediated synthesis of quinolines","volume":"130","author":"Sharma","year":"2018","journal-title":"J Chem Sci"},{"key":"10.1016\/j.ejps.2020.105596_bib0018","first-page":"1557","article-title":"Synthetic Methods of Quinoline Derivatives as Potent Anticancer Agents","author":"Sharma","year":"2017","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.ejps.2020.105596_bib0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/14756366.2014.930454","article-title":"Quinoline and quinolones: promising scaffolds for future antimycobacterial agents","author":"Singh","year":"2015","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.ejps.2020.105596_bib0021","series-title":"New drus approved for XDR-TB","year":"2019"},{"key":"10.1016\/j.ejps.2020.105596_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105374","article-title":"Pyridine and quinoline molecules as crucial protagonists in the never-stopping discovery of new agents against tuberculosis","author":"Villamizar-Mogotocoro","year":"2020","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejps.2020.105596_bib0024","series-title":"Global tuberculosis Information","year":"2020"},{"key":"10.1016\/j.ejps.2020.105596_bib0025","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1517\/17460441.2015.1041496","article-title":"Privileged scaffolds in lead generation","volume":"10","author":"Zhao","year":"2015","journal-title":"Expert Opin Drug Discov"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720303845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720303845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T19:09:41Z","timestamp":1769886581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720303845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":22,"alternative-id":["S0928098720303845"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105596","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial activity of new substituted 4-N-alkylated-2-trifluoromethyl-quinoline analogues against sensitive and resistant Mycobacterium tuberculosis strains","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105596"}}